Clinical trial
Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
NCT01310972 is registered in ClinicalTrials.gov with King Faisal Specialist Hospital & Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX
- Lead sponsor
- King Faisal Specialist Hospital & Research Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- September 30, 2007
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer